These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27307734)

  • 21. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis.
    Findlay S; Huber F; Garcia J; Huang L
    Ann Allergy; 1992 Mar; 68(3):228-32. PubMed ID: 1546817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis.
    Jeal W; Faulds D
    Drugs; 1997 Feb; 53(2):257-80. PubMed ID: 9028745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis.
    Welch MJ; Bronsky E; Findlay S; Pearlman DS; Southern DL; Storms WW; Weakley S
    Clin Ther; 1994; 16(2):253-62. PubMed ID: 8062320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin.
    Fahmy UA; Ahmed OAA; Badr-Eldin SM; Aldawsari HM; Okbazghi SZ; Awan ZA; Bakhrebah MA; Alomary MN; Abdulaal WH; Medina C; Alhakamy NA
    Int J Nanomedicine; 2020; 15():5253-5264. PubMed ID: 32801690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
    Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
    Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering of a hybrid polymer-lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: physicochemical, molecular, microstructural, and stability evaluation.
    Pokharkar VB; Jolly MR; Kumbhar DD
    Eur J Pharm Sci; 2015 Apr; 71():99-111. PubMed ID: 25708940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis.
    Bernstein DI; Creticos PS; Busse WW; Cohen R; Graft DF; Howland WC; Lumry WR; Pedinoff AJ; Ratner PH; Lim J; Stokes A; McNally C
    J Allergy Clin Immunol; 1996 Mar; 97(3):749-55. PubMed ID: 8613630
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Jing Z; Li W; Liao W; Lv Y; Liu Y; Jiang H; Feng Y
    Int J Nanomedicine; 2024; 19():1557-1570. PubMed ID: 38406606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
    Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model.
    Altuntaş E; Yener G; Doğan R; Aksoy F; Şerif Aydın M; Karataş E
    Am J Rhinol Allergy; 2018 May; 32(3):132-138. PubMed ID: 29644886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of intranasal triamcinolone acetonide with oral loratadine in the treatment of seasonal ragweed-induced allergic rhinitis.
    Gawchik SM; Lim J
    Am J Manag Care; 1997 Jul; 3(7):1052-8. PubMed ID: 10173369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability.
    Teng Z; Yu M; Ding Y; Zhang H; Shen Y; Jiang M; Liu P; Opoku-Damoah Y; Webster TJ; Zhou J
    Int J Nanomedicine; 2019; 14():119-133. PubMed ID: 30613141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
    Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
    Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of Simvastatin ex vivo Permeation from Mucoadhesive Buccal Films Loaded with Dual Drug Release Carriers.
    Ahmed TA; Bawazir AO; Alharbi WS; Safo MK
    Int J Nanomedicine; 2020; 15():4001-4020. PubMed ID: 32606661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study.
    Pokharkar V; Patil-Gadhe A; Palla P
    Biomed Pharmacother; 2017 Oct; 94():150-164. PubMed ID: 28759752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal Surface-Modified Mosapride Citrate-Loaded Nanostructured Lipid Carriers (MOS-SMNLCs) for Treatment of Reflux Diseases: In vitro Optimization, Pharmacodynamics, and Pharmacokinetic Studies.
    Hammad RW; Sanad RAB; Abdelmalk NS; Aziz RL; Torad FA
    AAPS PharmSciTech; 2018 Nov; 19(8):3791-3808. PubMed ID: 30280358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine.
    Luppi B; Bigucci F; Corace G; Delucca A; Cerchiara T; Sorrenti M; Catenacci L; Di Pietra AM; Zecchi V
    Eur J Pharm Sci; 2011 Nov; 44(4):559-65. PubMed ID: 22009109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of treatment with intranasal corticosteroids on the nasal mucosa, weight, and corticosteroid concentration in rats.
    Park DM; Carvalho TL; Franci JA; Anselmo-Lima WT
    Am J Rhinol Allergy; 2012; 26(1):e46-9. PubMed ID: 22182666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.